INS and Insulin resistance: One-year treatment with genistein, at a daily dose of 54 mg, of Caucasian postmenopausal women with metabolic syndrome, resulted in a decrease of fasting glucose, fasting insulin, and insulin resistance, total cholesterol, LDL-C, triglycerides, visfatin, homocysteine and an increase of HDL-c and adiponectin [149].